Alice Chen Fan, MD is a Internal Medicine Physician - Medical Oncology practicing in Palo Alto, CA
She has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Albany Medical College of Union University | Medical Degree | 1998 |
| Institution | Focus | Year |
|---|---|---|
| Residency - Brown University - School of Medicine | 2001 | |
| Residency - Brown University School Of Med | Not Specified | |
| Internship - Brown Universities | 1999 | |
| Fellowship - Stanford University Medical Center, Stanford Ca - Bariatric Surgery | 2006 |
| Certification | Cert. Body | Year |
|---|---|---|
| Internal medicine Sub-Specialty: Medical Oncology | Internal Medicine | Not Specified |
Sub-Specialty: Medical Oncology | Internal Medicine | 2004 |
| Internal medicine | Internal Medicine | 2001 |
| Position | Organization | Time |
|---|---|---|
| Assistant Professor of Medicine (Oncology) | the Stanford University Medical Center | Present |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | ONCOTARGET | Picolog, a Synthetically-Available Bryostatin Alog, Inhibits Growth of MYC-Induced Lymphoma In Vivo | 2012 |
| Other Publication | TURE MEDICINE | nofluidic proteomic assay for serial alysis of oncoprotein activation in clinical specimens | 2009 |
| Other Publication | ANGEWANDTE CHEMIE-INTERTIOL EDITION | Supramolecular Stacking of Doxorubicin on Carbon notubes for In Vivo Cancer Therapy | 2009 |
| Other Publication | MOLECULAR CANCER | A quantitative PCR method to detect blood microRs associated with tumorigenesis in transgenic mice | 2008 |
| Other Publication | PLOS ONE | Combined Ictivation of MYC and K | 2008 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | Apoptosis-stimulating protein of p53 | 2009 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | Cellular senescence is an important mechanism of tumor regression upon c-Myc ictivation | 2007 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | Sustained regression of tumors upon MYC ictivation requires p53 or thrombospondin | 2006 |
| Other Publication | SEMIRS IN CANCER BIOLOGY | Conditiol animal models | 2004 |
| Other Publication | LEUKEMIA RESEARCH | Treatment of higher risk myelodyspl | 2012 |
| Other Publication | ONCOTARGET | Picolog, a Synthetically-Available Bryostatin Analog | 2012 |
| Other Publication | NATURE MEDICINE | Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens | 2009 |
| Other Publication | ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | Supramolecular Stacking of Doxorubicin on Carbon Nanotubes for In Vivo Cancer Therapy | 2009 |
| Other Publication | MOLECULAR CANCER | A quantitative PCR method to detect blood microRNAs associated with tumorigenesis | 2008 |
| Other Publication | PLOS ONE | Combined Inactivation of MYC and K | 2008 |
| Other Publication | Blood | BCL-2 inhibition with ABT-737 prolongs survival in an NRAS | 2013 |
| Other Publication | Molecular cancer therapeutics | A c-Myc Activation Sensor | 2013 |
| Other Publication | BMJ case reports | Cryptococcal osteomyelitis | 2012 |
| Other Publication | CANCER RESEARCH | Definition of an Enhanced Immune Cell Therapy in Mice That Can Target Stem-Like Lymphoma Cells | 2010 |
| Other Publication | CANCER CELL | CD4(+) T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor | 2010 |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | Apoptosis-stimulating protein of p53 | 2009 |
| Other Publication | BLOOD | Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis | 2007 |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation | 2007 |
| Other Publication | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O | Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin | 2006 |
| Other Publication | SEMINARS IN CANCER BIOLOGY | Conditional animal models | 2004 |
| Other Publication | CANCER | p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma | 2000 |
Years In Practice: 20 (started in 2005)
Accepts New Patients: Yes
Alice Chen Fan, MD has not yet listed the medications that she commonly prescribes.
Alice Chen Fan, MD has not yet specified the insurance plans she accepts.
